Long-acting GHRH + selective GHRP. Convenient once or twice weekly CJC-1295 DAC combined with daily Ipamorelin.
The combination of Ipamorelin and CJC-1295 with DAC represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.
Ipamorelin primarily acts via selective ghrelin receptor (ghsr) agonist that stimulates pulsatile gh release with minimal effect on cortisol or prolactin., while CJC-1295 with DAC complements this by long-acting ghrh analog with a drug affinity complex that binds albumin, extending half-life to 6-8 days for sustained gh elevation.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.
Ipamorelin Targets
CJC-1295 with DAC Targets
Systemic effectsStart This Protocol
Alukard provides physician-supervised longevity protocols, including the Ipamorelin + CJC-1295 with DAC stack, with GMP-certified compounds and comprehensive biomarker testing.
Get Physician ConsultationBegin Your Age Reversal Protocol for Ipamorelin + CJC-1295 with DAC Stack
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing